Skip to main content
Equibles

SPRC · SciSparc Ltd.

Track SPRC — free

Use SPRC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SPRC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.38 -0.02 (-1.46%)
Rebalance outlook locked
Market Cap
$32.30M
Shares
23.07M
Volume · Oct 20 40.47K Avg daily vol (3M) 717.33K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.40 Open$1.63 Day$1.40–1.72 52W close$1.40–38.79 Avg vol 30d1.2M Short int11K · 0.0% float · 1.0d Short vol24% DataAug 2021–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$679,000
Trailing 12 months
Net income (TTM)
−$8.22M
Trailing 12 months
Revenue growth YoY
-34.5%
Year over year
Operating margin
-1,553.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-29.1%
Year over year · fewer shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 116 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −77%
below
Price vs 50-day avg −73%
below
RSI (14) 16
oversold
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −69%
trailing
6-month return −83%
trailing
YTD return −89%
this year
Relative strength −91%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Accumulating
+125% holders QoQ · +6 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.05% of float · ▲ +3.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Squeeze score 31
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 205%
annualized · 1-yr
Max drawdown −96%
past year
ATR 42.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−77% Bearish
Price vs 50-day avg
−73% Bearish
RSI (14)
16 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $5 › 200d $6 — 200d above 50d
Institutional flow Accumulating
+125% holders QoQ · +6 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.05% of float · ▲ +3.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
9 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 0% Range high $39
vs 200-day avg -77% vs 50-day avg -73%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SPRC
SciSparc Ltd.
this stock
$32.30M — — — 0.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.07B +10.7% +46.2% 29.9 1.8%
MRNA
Moderna, Inc.
 $90.58B +669.4% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.51B +1.3% +20.8% 19.4 2.1%
CSLLY
Csl Ltd
 $64.50B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
9
% held
0.2%
Net QoQ
+50.5K sh
Top holder
HRT FINANCIAL LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
11.4K
Days to cover
1.0d
Change
+389 sh
View
Short Volume
Short vol %
24%
As of
Oct 19, 2026
Short Total
View
Fails to Deliver
FTD shares
716
Value
$3.6K
As of
Sep 24, 2026
View
Off-Exchange
Off-exchange %
38.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 15, 2026
This year
33

SciSparc Ltd. offered L.I.A Pure Capital Ltd. conversion of $2,023,039.21 in outstanding note principal and accrued interest into ordinary shares at $1.50 per Ordinary Share, with no cash proceeds to SciSparc and closing expected on or about October 16, 2026.

View
Proposed Sales
Value
$583.9K
Shares
73.9K
Filed
Jun 22, 2026
View
Exempt Offerings
Offering
$4.2M
Filed
Mar 3, 2025
View

Performance

5D 20D 120D MTD YTD
SPRC -65.7% -69.1% -83.2% -70.3% -88.6%
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY -64.2% -68.2% -90.9% -70.8% -101.0%
Key facts CIK 1611746 CUSIP M82618139 Visit website Investor relations